References
- World Health Organization . Novel Coronavirus (2019-nCoV). Situation report - 1 (2020). www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4 (Accessed 20December2021).
- World Health Organization . Novel Coronavirus (2019-nCoV). Situation report - 22 (2020). www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf?sfvrsn=fb6d49b1_2 (Accessed 20December2021).
- World Health Organization . WHO Director-General's opening remarks at the media briefing on COVID-19 – 11 March 2020 (2020). www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (Accessed 20December, 2021).
- Shu Y , McCauleyJ. GISAID: global initiative on sharing all influenza data – from vision to reality. Euro Surveill.22(13), 30494 (2017).
- Hadfield J , MegillC , BellSMet al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics.34(23), 4121–4123 (2018).
- Rambaut A , HolmesEC , O'TooleÁet al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol.5(11), 1403–1407 (2020).
- World Health Organization . Tracking SARS-CoV-2 variants. (2022). www.who.int/activities/tracking-SARS-CoV-2-variants/tracking-SARS-CoV-2-variants (Accessed 30July2022).
- World Health Organization . WHO announces simple, easy-to-say labels for SARS-CoV-2 Variants of Interest and Concern (2021). www.who.int/news/item/31-05-2021-who-announces-simple-easy-to-say-labels-for-sars-cov-2-variants-of-interest-and-concern (Accessed 20December2021).
- Huang Y , YangC , XuXF , XuW , LiuSW. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta. Pharmacol. Sin.41(9), 1141–1149 (2020).
- Li C , TianX , JiaXet al. The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2. Sig. Transduct. Target Ther.6, 132 Doi:10.1038/s41392-021-00536-0 (2021).
- Schrörs B , Riesgo-FerreiroP , SornPet al. Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates. PlOS ONE.16(9), e0249254 (2021).
- Safari I , ElahiE. Evolution of the SARS-CoV-2 genome and emergence of variants of concern. Arch. Virol.167(2), 293–305 (2022).
- SARS-CoV-2 Variants . Standford Coronavirus Antiviral & Resistance Database (CoVDB). (2023). https://covdb.stanford.edu/page/mutation-viewer/ (Accessed 10April2022).
- Desingu PA , NagarajanK , DhamaK. Emergence of Omicron third lineage BA.3 and its importance. J. Med. Virol.94(5), 1808–1810 (2022).
- European Centre for Disease Prevention and Control . Epidemiological update: SARS-CoV-2 Omicron sub-lineages BA.4 and BA.5 (2022). www.ecdc.europa.eu/en/news-events/epidemiological-update-sars-cov-2-omicron-sub-lineages-ba4-and-ba5 (Accessed 28May2022).
- Kudriavtsev AV , VakhrushevaAV , NovoseletskyVNet al. Immune escape associated with RBD Omicron mutations and SARS-CoV-2 evolution dynamics. Viruses.14(8), 1603 (2022).
- Gobeil SM , JanowskaK , McDowellSet al. Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity. Science373(6555), eabi6226 (2021).
- Barton MI , MacGowanSA , KutuzovMA , DushekO , BartonGJ , vander Merwe PA. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Elife.10, e70658 Doi:10.7554/eLife.70658 (2021).
- Wu F , ZhaoS , YuBet al. A new coronavirus associated with human respiratory disease in China. Nature579(7798), 265–269 (2020).
- Grantham R . Amino acid difference formula to help explain protein evolution. Science185(4154), 862–864 (1974).
- Li WH , WuCI , LuoCC. Nonrandomness of point mutation as reflected in nucleotide substitutions in pseudogenes and its evolutionary implications. J. Mol. Evol.21(1), 58–71 (1984).
- Sim NL , KumarP , HuJ , HenikoffS , SchneiderG , NgPC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res.40(Web Server issue), W452–W457 (2012).
- Choi Y , SimsGE , MurphyS , MillerJR , ChanAP. Predicting the functional effect of amino acid substitutions and indels. PLOS ONE.7(10), e46688 (2012).
- Hecht M , BrombergY , RostB. Better prediction of functional effects for sequence variants. BMC Genomics.16(Suppl. 8), S1 (2015).
- Suzek BE , WangY , HuangH , McGarveyPB , WuCH. UniProt Consortium. UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches. Bioinformatics.31(6), 926–932 (2015).
- Wang Q , ZhangY , WuLet al. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell181(4), 894–904.e9 (2020).
- Guex N , PeitschMC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis18(15), 2714–2723 (1997).
- Han P , SuC , ZhangYet al. Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants. Nat. Commun.12(1), 6103 (2021).
- Han P , LiL , LiuSet al. Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2. Cell185(4), 630–640.e10 (2022).
- van Gunsteren WF , BilleterSR , EisingAAet al. Biomolecular Simulation: The GROMOS96 Manual and User Guide. Biomos, Zürich, Federal Republic of Germany (1996).
- Dehouck Y , KwasigrochJM , RoomanM , GilisD. BeAtMuSiC: prediction of changes in protein-protein binding affinity on mutations. Nucleic Acids Res.41(Web Server issue), W333–W339 (2013).
- Xiong P , ZhangC , ZhengW , ZhangY. BindProfX: Assessing Mutation-Induced Binding Affinity Change by Protein Interface Profiles with Pseudo-Counts. J. Mol. Biol.429(3), 426–434 (2017).
- Zhang N , ChenY , LuHet al. MutaBind2: Predicting the Impacts of Single and Multiple Mutations on Protein-Protein Interactions. iScience.23(3), 100939 (2020).
- Pahari S , LiG , MurthyAKet al. SAAMBE-3D: predicting effect of mutations on protein–protein interactions. Int. J. Mol. Sci.21(7), 2563 (2020).
- Rodrigues CHM , PiresDEV , AscherDB. mmCSM-PPI: predicting the effects of multiple point mutations on protein-protein interactions. Nucleic Acids Res.49(W1), W417–W424 (2021).
- Genheden S , RydeU. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert opinion on drug discovery.10(5), 449–461 (2015).
- Weng G , WangE , WangZet al. HawkDock: a web server to predict and analyze the protein-protein complex based on computational docking and MM/GBSA. Nucleic Acids Res.47(W1), W322–W330 (2019).
- Schrödinger L , DeLanoW. PyMOL (2020). http://www.pymol.org/pymol (Accessed 22March2022).
- Du X , LiY , XiaYLet al. Insights into Protein-Ligand Interactions: Mechanisms, Models, and Methods. Int. J. Mol. Sci.17(2), 144 (2016).
- Hou T , WangJ , LiY , WangW. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model.51(1), 69–82 (2011).
- Tian D , SunY , XuH , YeQ. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J. Med. Virol.94(6), 2376–2383 (2022).
- Chaguza C , CoppiA , EarnestRet al. Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons. Med (N Y).3(5), 325–334.e4 (2022).
- Araf Y , AkterF , TangYDet al. Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines. J. Med. Virol.94(5), 1825–1832 (2022).
- World Health Organization . Enhancing response to Omicron SARS-CoV-2 variant: technical brief and priority actions for Member States World (2022). https://www.who.int/docs/default-source/coronaviruse/2022-01-21-global-technical-brief-and-priority-action-on-omicron-sars-cov-2-variant.pdf?sfvrsn=f3ac8bc3_9&download=true (Accessed 14February2022).
- Ali F , KasryA , AminM. The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant. Med Drug Discov.10, 100086 Doi:10.1016/j.medidd.2021.100086 (2021).
- Lu L , ChuAW , ZhangRRet al. The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum. EBioMedicine.71, 103544 Doi:10.1016/j.ebiom.2021.103544 (2021).
- Tian F , TongB , SunLet al. N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2. Elife.10, e69091 Doi:10.7554/eLife.69091 (2021).
- Liu Y , LiuJ , PlanteKSet al. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. Nature602(7896), 294–299 (2022).
- Nguyen KV . Problems associated with antiviral drugs and vaccines development for COVID-19: approach to intervention using expression vectors via GPI anchor. Nucleosides Nucleotides Nucleic Acids.40(6), 665–706 (2021).
- Motozono C , ToyodaM , ZahradnikJet al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe.29(7), 1124–1136.e11 (2021).
- Tchesnokova V , KulasekaraH , LarsonLet al. Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants. J. Clin. Microbiol.59(11), e0092121 (2021).
- Zhang Y , ZhangT , FangY , LiuJ , YeQ , DingL. SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis. Signal. Transduct. Target Ther.7(1), 76 (2022).
- Liu L , IketaniS , GuoYet al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature602(7898), 676–681 (2022).
- Novazzi F , BajA , PasciutaRet al. Acluster of SARS-CoV-2 Delta variant of concern additionally harboring F490S, Northern Lombardy, Italy. Int. J. Infect. Dis.116, 271–272 Doi:10.1016/j.ijid.2021.12.362 (2022).
- Cao Y , WangJ , JianFet al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature602(7898), 657–663 (2022).
- Alkhatib M , SalpiniR , CariotiLet al. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile. Microbiol. Spectr.10(2), e0273221 (2022).
- Kullappan M , MaryU , AmbroseJM , VeeraraghavanVP , SurapaneniKM. Elucidating the role of N440K mutation in SARS-CoV-2 spike - ACE-2 binding affinity and COVID-19 severity by virtual screening, molecular docking and dynamics approach. J Biomol Struct Dyn.41(3), 912–929 (2021).
- Verma J , SubbaraoN. Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability. Virology561, 107–116 Doi:10.1016/j.virol.2021.06.009 (2021).
- Goher SS , AliF , AminM. The Delta variant mutations in the receptor binding domain of SARS-CoV-2 show enhanced electrostatic interactions with the ACE2. Med. Drug Discov.13, 100114 Doi:10.1016/j.medidd.2021.100114 (2021).
- Celik I , KhanA , DwivanyFM , Fatimawali , WeiDQ , TalleiTE. Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2. Mol Divers.26(6), 3309–3324 (2022).
- Harvey WT , CarabelliAM , JacksonBet al. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol.19, 409–424 Doi:10.1038/s41579-021-00573-0 (2021).
- Rayati Damavandi A , DowranR , AlSharif Set al. Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy. Med. Microbiol. Immunol.211(2–3), 79–103 (2022).
- Yamacli S , AvciM. Computation of the Binding Energies between Human ACE2 and Spike RBDs of the Original Strain, Delta and Omicron Variants of the SARS-CoV-2: A DFT Simulation Approach. Adv. Theory Simul.5, 2200337 Doi:10.1002/adts.202200337 (2022).
- Nguyen HL , ThaiNQ , NguyenPH , LiMS. SARS-CoV-2 Omicron Variant Binds to Human Cells More Strongly than the Wild Type: Evidence from Molecular Dynamics Simulation. J. Phys. Chem. B. B.126(25), 4669–4678 (2022).
- Ortega JT , JastrzebskaB , RangelHR. Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: an In Silico Analysis. Pathogens.11(1), 45 (2021).
- Shah M , WooHG. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies. Front Immunol.12, 830527 Doi:10.3389/fimmu.2021.830527 (2022).
- Lupala CS , YeY , ChenH , SuXD , LiuH. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor. Biochem. Biophys. Res. Commun.590, 34–41 Doi:10.1016/j.bbrc.2021.12.079 (2022).
- Kapoor K , ChenT , TajkhorshidE. Posttranslational modifications optimize the ability of SARS-CoV-2 spike for effective interaction with host cell receptors. Proc. Natl Acad, Sci, U S A.119(28), e2119761119 (2022).
- Gong Y , QinS , DaiL , TianZ. The glycosylation in SARS-CoV-2 and its receptor ACE2. Sig. Transduct. Target Ther.6, 396 Doi:10.1038/s41392-021-00809-8 (2021).
- Sztain T , AhnSH , BogettiATet al. A glycan gate controls opening of the SARS-CoV-2 spike protein. Nat. Chem.13, 963–968 Doi:10.1038/s41557-021-00758-3 (2021).
- López-Cortés GI , Palacios-PérezM , VeledíazHFet al. The Spike Protein of SARS-CoV-2 Is Adapting Because of Selective Pressures. Vaccines (Basel).10(6), 864 (2022).
- Cameroni E , BowenJE , RosenLEet al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature602, 664–670 Doi:10.1038/s41586-021-04386-2 (2022).
- Yi C , SunX , LinYet al. Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants. Genome Med.13, 164 Doi:10.1186/s13073-021-00985-w (2021).
- Bashor L , GagneRB , Bosco-LauthAM , BowenRA , StengleinM , VandeWoudeS. SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection. Proc. Natl Acad. Sci. U S A118(44), e2105253118 (2021).
- Meekins DA , GaudreaultNN , RichtJA. Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals. Viruses.13(10), 1993 (2021).